Predisposition footprints in the somatic genome of Wilms tumours
Taryn D. Treger,Jenny Wegert,Anna Wenger,Tim H. H. Coorens,Reem Al-Saadi,Paul G. Kemps,Jonathan Kennedy,Conor Parks,Nathaniel D. Anderson,Angus Hodder,Aleksandra Letunovska,Hyunchul Jung,Toochi Ogbonnah,Mi K. Trinh,Henry Lee-Six,Guillaume Morcrette,Marry M. van den Heuvel-Eibrink,Jarno Drost,Ruben van Boxtel,Eline J.M. Bertrums,Bianca F. Goemans,Evangelia Antoniou,Dirk Reinhardt,Heike Streitenberger,Barbara Ziegler,Jack Bartram,J. Ciaran Hutchinson,Gordan M. Vujanic,Christian Vokuhl,Tanzina Chowdhury,Rhoikos Furtwängler,Norbert Graf,Kathy Pritchard-Jones,Manfred Gessler,Sam Behjati
DOI: https://doi.org/10.1158/2159-8290.cd-24-0878
IF: 28.2
2024-12-14
Cancer Discovery
Abstract:Ten percent of children with cancer harbour a mutation in a predisposition gene. In children with the kidney cancer, Wilms tumour, the prevalence is as high as 30%. Certain predispositions are associated with defined histological and clinical features, suggesting differences in tumourigenesis. To investigate this, we assembled a cohort of 137 children with Wilms tumour, of whom 71 had a pathogenic germline or mosaic variant. We examined 237 neoplasms (including two secondary leukaemias), utilising WGS, RNA sequencing and genome wide methylation, validating our findings in an independent cohort. Tumour development differed in children harbouring a predisposition, depending on the variant gene and its developmental timing. Differences pervaded the repertoire of driver events, including high risk mutations, the clonal architecture of normal kidneys, and the relatedness of neoplasms from the same individual. Our findings indicate that predisposition may preordain Wilms tumourigenesis, suggesting a variant specific approach to managing children merits consideration.
oncology